Aveanna Healthcare Holdings, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Talkspace, Inc.

Enhabit, Inc.

Aveanna Healthcare Holdings, Inc.

The Pennant Group, Inc.

Pediatrix Medical Group, Inc.

LifeMD, Inc.

Fulgent Genetics, Inc.

OPKO Health, Inc.

CareMax, Inc.

DocGo, Inc.

Celldex Therapeutics, Inc.

Why is Aveanna Healthcare Holdings, Inc. ?

With a growth in Net Profit of 1170.99%, the company declared Very Positive results in Sep 25

The company has declared positive results for the last 7 consecutive quarters
OPERATING CASH FLOW(Y) Highest at USD 83.73 MM
NET SALES(Q) Highest at USD 621.94 MM
NET PROFIT(Q) At USD 28.77 MM has Grown at 107.78%

With ROE of 1000.90%, it has a very attractive valuation with a 156.27 Price to Book Value

Over the past year, while the stock has generated a return of 18.46%, its profits have risen by 2652.1% ; the PEG ratio of the company is 0

Consistent Returns over the last 3 years

Along with generating 18.46% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Aveanna Healthcare Holdings, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Aveanna Healthcare Holdings, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Aveanna Healthcare Holdings, Inc.

18.64%

2.35

70.02%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

91.03%

EBIT Growth (5y)

48.71%

EBIT to Interest (avg)

1.37

Debt to EBITDA (avg)

9.28

Net Debt to Equity (avg)

-13.90

Sales to Capital Employed (avg)

1.49

Tax Ratio

60.41%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

98.63%

ROCE (avg)

8.81%

ROE (avg)

2.71%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

156.27

EV to EBIT

11.61

EV to EBITDA

10.39

EV to Capital Employed

2.06

EV to Sales

1.21

PEG Ratio

0.01

Dividend Yield

ROCE (Latest)

17.73%

ROE (Latest)

1000.90%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 83.73 MM

NET SALES(Q)

Highest at USD 621.94 MM

NET PROFIT(Q)

At USD 28.77 MM has Grown at 107.78%

RAW MATERIAL COST(Y)

Fallen by -4.42% (YoY

-1What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 14,854 %

Here's what is working for Aveanna Healthcare Holdings, Inc.

Operating Cash Flow

Highest at USD 83.73 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales

Highest at USD 621.94 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (USD MM)

Net Profit

At USD 28.77 MM has Grown at 107.78%

over average net sales of the previous four periods of USD 13.85 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Raw Material Cost

Fallen by -4.42% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Aveanna Healthcare Holdings, Inc.

Debt-Equity Ratio

Highest at 14,854 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio